Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03491826
Recruitment Status : Completed
First Posted : April 9, 2018
Last Update Posted : April 9, 2018
Sponsor:
Collaborator:
Hend Mostafa Hussein Salem
Information provided by (Responsible Party):
sarah mohamed hassan, Kasr El Aini Hospital

Brief Summary:
The aim of this study is to compare fetal and maternal outcome in cases of PPROM before 34 weeks versus after 34 weeks.

Condition or disease Intervention/treatment
Premature Rupture of Membrane Biological: rupture of membrane

Detailed Description:
The data will be retrieved from the archival files and analyzed

Layout table for study information
Study Type : Observational
Actual Enrollment : 1011 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM) at AIN Shams Maternity Hospital: A Retrospective Analysis of Last Five Years Admissions
Actual Study Start Date : January 2010
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tears

Group/Cohort Intervention/treatment
ROM before 34 weeks (A)
premature rupture of membrane before 34 weeks
Biological: rupture of membrane
ROM after 34 weeks (B)
premature rupture of membrane after 34 weeks
Biological: rupture of membrane



Primary Outcome Measures :
  1. maternal mortality [ Time Frame: up to 48 hours after delivery ]
    maternal mortality



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   24 Years to 39 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
pregnant female with history of rupture membrane
Criteria

Inclusion Criteria:

  • rupture of membrane

Exclusion Criteria:

  • medical disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03491826


Locations
Layout table for location information
Egypt
Kasr El Ainiy Hospital
Cairo, Egypt, 11562
Sponsors and Collaborators
sarah mohamed hassan
Hend Mostafa Hussein Salem

Layout table for additonal information
Responsible Party: sarah mohamed hassan, lecturer of obstetrics and gynecology, Kasr El Aini Hospital
ClinicalTrials.gov Identifier: NCT03491826    
Other Study ID Numbers: 123
First Posted: April 9, 2018    Key Record Dates
Last Update Posted: April 9, 2018
Last Verified: April 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Fetal Membranes, Premature Rupture
Rupture
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Wounds and Injuries